Results of a 12-month, multicenter, randomized trial of everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in De Novo cardiac transplant recipients

被引：0
|
作者：
Lebmkuhl, H. [1 ]
Livi, U. [2 ]
Arizon, J. [3 ]
Vigano, M. [4 ]
Magelli, C. [5 ]
Boissonnat, P. [6 ]
Gerosa, G. [7 ]
Musumeci, F. [8 ]
Gandjbakhch, I. [9 ]
Vanhaecke, J. [10 ]
Hexham, J. M. [11 ]
Mange, K. C. [11 ]
机构：
[1] Deutsch Herzzentrum Berlin, Berlin, Germany
[2] Osped S Maria Misericordia, Udine, Italy
[3] Hosp Univ Reina Sofia, Cordoba, Spain
[4] Univ Pavia, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy
[5] Az Osp Bologna, Policlin S Orsola, Bologna, Italy
[6] Hop Cardiol Lyon, Lyon, France
[7] Univ Padua, Azienda Osped Padova, Padua, Italy
[8] Osped S Camillo Forlanini Azienda Osped Circonval, Rome, Italy
[9] Hop La Pitie Salpetriere, Serv Chirurg Thorac & Cardiovasc, Paris, France
[10] Univ Hosp Gasthuisberg, Louvain, Belgium
[11] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15
引用
下载
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [41] A randomized, prospective, multicenter comparison of tacrolimus(TAC), mycophenolate mofetil (MMF) and steroids vs cyclosporine microemulsion, mmf and steroids vs TAC, sirolimus and steroids in de novo cardiac transplant recipients 12 month report.
    Kobashigawa, JA
    Miller, LW
    Russell, SD
    Ewald, GA
    Zucker, M
    First, R
    Fitzsimmons, W
    Salm, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 250 - 250
  • [42] Excellent graft function in de novo kidney transplant recipients treated with Certican®, Simulect® and reduced Neoral® exposure:: 12-month results.
    Whelchel, J
    Vitko, S
    Eris, J
    Campbell, S
    Burbigott, B
    Leone, J
    Rigotti, P
    Haas, T
    Jappe, A
    Cretin, N
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 297 - 297
  • [43] The impact on renal function of an early reduction of cyclosporine in de novo cardiac transplant under MMF:: Results of a french multicenter prospective randomized study
    Boissonnat, P.
    Noel-Baron, F.
    Gaillard, S.
    Mercier, C.
    Roussoulieres, A.
    Sebbag, I.
    Bastien, O.
    Redonnet, M.
    Lelong, B.
    Mattei, M. -F.
    Mouly-Bandini, A.
    Treilhaud, M.
    Pattier, S.
    Sirinelli, A.
    Epailly, E.
    Thiranos, J. -C.
    Varnous, S.
    Billes, M. -A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S228 - S228
  • [44] Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
    Vitko, S
    Margreiter, R
    Weimar, W
    Dantal, J
    Viljoen, HG
    Li, YL
    Jappe, A
    Cretin, N
    TRANSPLANTATION, 2004, 78 (10) : 1532 - 1540
  • [45] Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in Japanese De Novo Renal Transplant Recipients: Efficacy and Safety Results at 12 Months: Japanese Multicenter Study
    Yoshimura, N.
    Uchida, K.
    Takahara, S.
    Teraoka, S.
    Kobayashi, E.
    Teshima, R.
    Cornu-Artis, C.
    Takahashi, K.
    TRANSPLANTATION, 2012, 94 (10) : 990 - 990
  • [46] A Retrospective Comparison of Mycophenolate Mofetil with Low-Exposure Cyclosporine Versus Standard Cyclosporine Therapy in De Novo Liver Transplant Patients
    Senft, Jonas D.
    Gotthardt, Daniel N.
    Frischbier, Lina
    Bruns, Helge
    Schemmer, Peter
    ANNALS OF TRANSPLANTATION, 2015, 20 : 539 - 543
  • [47] Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder Singh
    Lee, Wei-Chen
    Suh, Kyung-Suk
    Joo, Dong Jin
    Uemoto, Shinji
    Joh, Jaewon
    Yoshizumi, Tomoharu
    Yang, Horng-Ren
    Song, Gi-Won
    Lopez, Patricia
    Kochuparampil, Jossy
    Sips, Carole
    Kaneko, Shuhei
    Levy, Gary
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (06) : 1435 - 1446
  • [48] THE TRANSFORM STUDY: 12-MONTH EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS
    Pascual, Julio
    Berger, Stefan
    Witzke, Oliver
    Chadban, Steve
    Oppenheimer, Federico
    Oberbauer, Rainer
    Watarai, Yoshihiko
    Legendre, Christophe
    Luo, Wen-Lin
    Marti, Anamaria
    Bernhardt, Peter
    Tedesco, Helio
    TRANSPLANT INTERNATIONAL, 2017, 30 : 159 - 159
  • [49] Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy
    Sommerer, Claudia
    Duerr, Michael
    Witzke, Oliver
    Lehner, Frank
    Arns, Wolfgang
    Kliem, Volker
    Ackermann, Daniel
    Guba, Markus
    Jacobi, Johannes
    Hauser, Ingeborg A.
    Stahl, Rolf
    Reinke, Petra
    Rath, Thomas
    Veit, Justyna
    Mehrabi, Arianeb
    Porstner, Martina
    Budde, Klemens
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 (12) : 2965 - 2976
  • [50] Comparable efficacy-safety and better renal function with everolimus and reduced-exposure tacrolimus versus standard-exposure tacrolimus in liver transplant recipients: H2304 and H2307 pooled analysis
    Levy, G.
    Lee, S. G.
    Jeng, L. -B
    Soin, A. S.
    Lee, W. -C
    De Simone, P.
    Nevens, F.
    Suh, K. -S
    Fischer, L.
    Joo, D. J.
    Fung, J.
    Joh, J. -W
    Kaido, T.
    Grant, D.
    Meier, M.
    Sips, C.
    Kaneko, S.
    Saliba, F.
    TRANSPLANTATION, 2019, 103 (08) : 36 - 36
12345